Olmesartan-Associated Enteropathy: An Uncommon Cause of Chronic Diarrhea
- PMID: 40735728
- PMCID: PMC12305112
- DOI: 10.1002/ccr3.70706
Olmesartan-Associated Enteropathy: An Uncommon Cause of Chronic Diarrhea
Abstract
Olmesartan-associated sprue-like enteropathy is an uncommon side effect and should be considered as a differential diagnosis in patients who are on Olmesartan and presenting with chronic unexplained diarrhea.
Keywords: Olmesartan; chronic diarrhea; drug‐induced enteropathy; sprue‐like enteropathy.
© 2025 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- “Approval Letter for Olmesartan,” (2025), https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21‐286_Benicar_A....
-
- Rubio‐Tapia A., Herman M. L., Ludvigsson J. F., et al., “Severe Spruelike Enteropathy Associated With Olmesartan,” Mayo Clinic Proceedings 87, no. 8 (2012): 732, https://pmc.ncbi.nlm.nih.gov/articles/PMC3538487/. - PMC - PubMed
-
- Degaetani M., Tennyson C. A., Lebwohl B., et al., “Villous Atrophy and Negative Celiac Serology: A Diagnostic and Therapeutic Dilemma,” American Journal of Gastroenterology 108, no. 5 (2013): 647–653, https://pubmed.ncbi.nlm.nih.gov/23644957/. - PubMed
-
- Ziegler T. R., Fernández‐Estívariz C., Gu L. H., Fried M. W., and Leader L. M., “Severe Villus Atrophy and Chronic Malabsorption Induced by Azathioprine,” Gastroenterology 124, no. 7 (2003): 1950–1957, https://pubmed.ncbi.nlm.nih.gov/12806628/. - PubMed
-
- Weclawiak H., Ould‐Mohamed A., Bournet B., et al., “Duodenal Villous Atrophy: A Cause of Chronic Diarrhea After Solid‐Organ Transplantation,” American Journal of Transplantation 11, no. 3 (2011): 575–582, https://pubmed.ncbi.nlm.nih.gov/21299830/. - PubMed
LinkOut - more resources
Full Text Sources
